| Buckeye Health Plan Ohio Medicaid Clinical | Glofitamab-gxbm (Columvi) | 2025-08-01 |
| Buckeye Health Plan Ohio Medicaid Clinical | Inebilizumab-cdon (Uplizna) | 2025-08-01 |
| Buckeye Health Plan Ohio Medicaid Clinical | Nogapendekin Alfa Inbakicept-pmln (Anktiva) | 2025-08-01 |
| Buckeye Health Plan Ohio Medicaid Clinical | Olipudase Alfa-rpcp (Xenpozyme) | 2025-08-01 |
| Buckeye Health Plan Ohio Medicaid Clinical | Tarlatamab-dlle (Imdelltra) | 2025-08-01 |
| Buckeye Health Plan Ohio Medicaid Clinical | Thyrotropin Alfa (Thyrogen) | 2025-08-01 |
| Buckeye Health Plan Ohio Medicaid Clinical | Tislelizumab-jsgr (Tevimbra) | 2025-08-01 |
| Medicare CGS | Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy (56881) | 2025-08-01 |
| Medicare CGS | Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis (59529) | 2025-08-01 |
| Medicare NGS | Billing and Coding: Genomic Sequence Analysis Panels in the Treatment of Hematolymphoid Diseases (56793) | 2025-08-01 |